Translational applications of microRNAs in cancer, and therapeutic implications

Citations of this article
Mendeley users who have this article in their library.


The search for targeted novel therapies for cancer is ongoing. MicroRNAs (miRNAs) display a number of characteristics making them an attractive and realisable option. In this review, we explore these applications, ranging from diagnostics, prognostics, disease surveillance, to being a primary therapy or a tool to sensitise patients to treatment modalities such as chemotherapy and radiotherapy. We take a particular perspective towards miRNAs and their impact on rare cancers. Advancement in the delivery of miRNAs, from viral vectors and liposomal delivery to nanoparticle based, has led to a number of pre-clinical and clinical applications for microRNA cancer therapeutics. This is promising, especially in the setting of rare cancers.




Kwok, G. T., Zhao, J. T., Weiss, J., Mugridge, N., Brahmbhatt, H., MacDiarmid, J. A., … Sidhu, S. B. (2017, September 1). Translational applications of microRNAs in cancer, and therapeutic implications. Non-Coding RNA Research. KeAi Communications Co.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free